rac-nor laudanosine
CAS: 13074-31-2
Rif. 3D-FR27650
| 1kg | Prezzo su richiesta | ||
| 2kg | Prezzo su richiesta | ||
| 5kg | Prezzo su richiesta | ||
| 10kg | Prezzo su richiesta | ||
| 500g | Prezzo su richiesta |
Informazioni sul prodotto
- 1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline1,2,3,4-Tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline (±)-N-Norlaudanosine
- (+/-)-Tetrahydropapaverine
- (±)-N-Norlaudanosine
- (±)-Norlaudanosine
- 1,2,3,4-Tetrahydropapaverine
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinolinium Chloride
- 1-[(3,4-Dimethoxyphenyl)Methyl]-1,2,3,4-Tetrahydro-6,7-Dimethoxyisoquinoline
- Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratryl-
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-
- Vedi altri sinonimi
Rac-nor laudanosine is a potent dopamine receptor agonist that is used for the treatment of Parkinson's disease. It has been shown to inhibit cell growth in culture and reduce acid formation, which may be due to its ability to inhibit cyclic nucleotide phosphodiesterases. Rac-nor laudanosine also inhibits the production of dopamine from tyrosine by inhibiting the conversion of dopamine into dihydroxyphenylalanine via the enzyme tyrosine hydroxylase. The asymmetric synthesis of rac-nor laudanosine allows it to have a high yield with less reaction time and fewer steps. This drug was shown to bind in vitro to human receptors.
Proprietà chimiche
Richiesta tecnica su: 3D-FR27650 rac-nor laudanosine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
